Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 22 May, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Recent Articles
- US Consumer Sentiment Plumbs Record Lows in May, Inflation Expectations Increase
- Lisa Su Doubles Down on Taiwan Capacity as Global CPU Market Tightens
- Thai Business Groups Urge Action on Worker Shortages as Costs Soar
- Northeast Asia Ships First Jet Fuel to Europe Since Iran War
- Pakistan's Lucky Motors Partners with China's GAC to Bet on EV Switch
- China to Expand Public Service Access for Migrant Workers
- Mexico, EU to Sign Stalled Trade Deal as They Aim to Diversify from US
- Americans Brace for Pricey Summer Travel with Fuel Costs Near Multi-Year Highs
- GoldSea Votes 2026: The Very Curious Asian Race to Replace Nancy Pelosi
- US-Sanctioned Industrial Giant Hengli Was Built from Scratch by Husband and Wife
